Work

O-51 Phase III study (TAX 326) of docetaxel-cisplatin (DC) and docetaxel-carboplatin (DCB) versus vinorelbine-cisplatin (VC) for the first-line treatment of advanced/metastatic non-small cell lung cancer (NSCLC): analyses in elderly patients

Year: 2003

Type: conference-abstract

Source: Lung Cancer

DOI: 10.1016/s0169-5002(03)91709-0

Authors: Chandra P. Belani, Frank V. Fossella

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2029962381

Cites:

Cited by: 45

Related to: 10